Prior to joining TME Pharma, Bryan served as Chief Financial Officer of Peptilogics, Inc. Previously, he was Chief Financial Officer for several private biotech firms including ChemomAb, Beren Therapeutics, Rational Vaccines, and KAHR Medical.
Prior to his CFO roles in biotech, Bryan was a senior member of the management team and a Managing Director at Morgan Stanley. In addition to running the firm's capital markets team in the Americas, he also spent significant time in the firm's mergers and acquisitions practice and worked for several years in London covering technology and healthcare companies as well. Earlier, Bryan began his Wall Street career and spent several years at Goldman Sachs.
Bryan received his Bachelor of Arts in Economics and Political Science from Williams College and his Masters in Business, with majors in Finance and Accounting, from The J.L. Kellogg School at Northwestern University.